Skip to main content

Table 2 List of nanomedicines targeting CNS diseases

From: Therapeutic nanoplatforms and delivery strategies for neurological disorders

 

Targeting disease

Loading molecule

Purpose

Material

Targeting strategy

Refs.

LBNP

GBM

Doxorubicin, vincristine

Anticancer

Liposome

T7 peptide

[11]

Doxorubicin

Anticancer

Liposome

Chlorotoxin

[8]

Doxorubicin

Anticancer

Liposome

IL-13

[9]

Coumarin-6

In vivo imaging

Liposome

RGD, Transferrin

[10]

AD

si-BACE

AD treatment

Exosome

Lamp-2b

[50]

PD

Dopamine HCl

PD treatment

Liposome

[30]

L-DOPA

PD treatment

Liposome

Chlorotoxin

[31]

PNP

GBM

Docetaxel

Anticancer

PEG‐PCL

AS14111 aptamer

[12]

Paclitaxel

Anticancer

PEG‐PLGA

AS14111 aptamer

[13]

Paclitaxel

Anticancer

PLGA

Transferrin

[14]

Paclitaxel

Anticancer

PEG-PLGA

Pep-1

[15]

Paclitaxel

Anticancer

PEG-PCL

Angiopep

[62]

AD

Curcumin

AD treatment

PBCA

ApoE3

[63]

PET

PBCA

125I-clioquinol

[64]

PD

α-synuclein

PD treatment

PBCA

ApoE

[65]

L-DOPA

PD treatment

PLGA

[59]

Nicotine

PD treatment

PLGA

[60]

Ropinirole-HCl

PD treatment

Chitosan

[58]

IO-NP

GBM

MRI

PEG-ION

Chlorotoxin

[84]

MRI

Dex-SIPON

Chitosan

[86]

MRI/TEM

PEG-ION

Anti-EGFRviii

[85]

AD

MRI

SPION

Anti-AβPP

[88]

MRI

Dextran-ION

Anti-ferritin

[89]

PD

Rhodamine-B

MRI

MION

[156]

Au-NP

GBM

Phthalocyanine 4

PDT

PEG-Au-NP

Transferrin peptide

[16]

PTT

PEG-Au-NP

[105]

PTT

PEG-Au-NP

RVG29 peptide

[17]

AD

Polyoxometalate

AD treatment

Au-NP

[138]

PD

Si-α-synuclein

PD treatment

Au-NP

Chitosan

[157]